BioWorld MedTech

June 14, 2018

FDA approves Wright's injectable bone graft

Wright Medical Group NV won FDA approval for its Augment injectable bone graft. As a result, the company plans to update its 2018 guidance on its second quarter earnings call. Read More

Vergent raises $8.7M series A to develop fluorescent solid tumor surgical probe

FDA takes another crack at commercial speech controversy

Singapore changes medical device requirements for faster market access

Brain sleepiness signature, links to memory identified

Other news to note

Daily M&A

Regulatory front

Appointments and advancements

Product briefs

Financings

BioWorld MedTech's Orthopedics Extra

Today's news in brief

BioWorld

BioWorld briefs for June 12, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

Skape Bio unlocks GPCR targets with de novo-designed miniproteins

BioWorld

Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...

Pre-disease plasma signature may help redefine lung cancer risk

BioWorld

Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...

New 5-HT2C receptor agonists reported in Hansoh patent

BioWorld Science

Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...